Symbiq Infusion Systems Recall
Hospira is issuing a Class 1 recall due to mishaps with the Symbiq infusion systems’ LCD touch screen.
About the Infusion System Recall
On occasion the touch screen fails to respond to the user, and in turn produces inaccurate readings. The inaccurate readings may lead to an interruption in a patient’s therapy.
A recent investigation has identified that the problem is rooted in the software. Facilities owning defective Symbiq infusion pumps should stop using the product immediately, and have the device tested for software malfunctions.
Description of Recalled Infusion Systems
- The recalled infusion systems are the 16026 Symbiq One-Channel Infuser and the 16027 Symbiq Two-Channel Infuser (all serial numbers).
- Only health care providers and facilities use the recalled product.
- The Symbiq infusion pumps can be tested for software malfunctions using actions described in the Symbiq technical service manual.
Contact an Experienced Product Liability Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of defective medications or medical devices, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.